Table 3. Cohort baseline characteristics of studying prognosis of breast cancer with ISLN metastasis.
Variables | Total, n (%) |
---|---|
Age, years | |
<50 | 49 (57.6) |
≥50 | 36 (42.4) |
Menopause | |
No | 45 (52.9) |
Yes | 40 (47.1) |
Clinical T stage | |
T1–2 | 62 (72.9) |
T3–4 | 23 (27.1) |
ER | |
Negative | 30 (35.3) |
Positive | 55 (64.7) |
PR | |
Negative | 36 (42.4) |
Positive | 49 (57.6) |
HER2 | |
Negative | 60 (70.6) |
Positive | 25 (29.4) |
aPCR | |
No | 54 (63.5) |
Yes | 31 (36.5) |
bPCR | |
No | 66 (77.6) |
Yes | 19 (22.4) |
sPCR | |
No | 41 (48.2) |
Yes | 44 (51.8) |